John Renger Sells 2,161 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) insider John Renger sold 2,161 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $41.54, for a total transaction of $89,767.94. Following the sale, the insider now directly owns 6,370 shares of […]
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) Director N Anthony Coles sold 2,506 shares of the stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $41.54, for a total transaction of $104,099.24. Following the transaction, the director now owns 15,638 shares in the company, valued […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Equities researchers at Wedbush decreased their FY2027 earnings per share (EPS) estimates for Rani Therapeutics in a research note issued to investors on Tuesday, February 6th. Wedbush analyst A. Argyrides now anticipates that the company will post earnings of ($1.78) per share for the year, down […]
Novel NK cell therapy approach is designed to bolster and replenish the immune system during severe viral infection, which can severely reduce immune cells leading to hospitalization and.